BIRC5 and cancer: Given the relevance of IAPs in cancer, multiple pharmacological inhibitors have been proposed with promising preclinical results.16, 17, 18 YM155 (sepantronium bromide) is a small molecule with antineoplastic potential that has been described as a suppressant of survivin and XIAP .